We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 35

Leave to appeal to the Court of Appeal Re: motion to strike pleadings granted in respect of claims to unjust enrichment, denied in respect of claims under the Trade-Marks Act

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 6 2013

In this case, Apotex has sued Eli Lilly for damages pursuant to s. 8 of the Patented Medicines (Notice of Compliance) Regulations. Eli Lilly brought a

Industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 2 2012

Bill C-11, The Copyright Modernization Act has received Royal Assent

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 2 2012

As we mentioned last week, CIPO is consulting on practice respecting inventive concept, statutory subject matter, diagnostic methods and medical uses

Appeal dismissed regarding motion granting leave to amend pleadings

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 12 2012

The Federal Court of Appeal (FCA) upheld a decision of the Motions Judge, which upheld the decision of a Prothonotary, granting leave to the respondents to amend their pleadings

Production of product and manufacturing information denied

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 10 2011

This is an appeal of a decision of a Prothonotary, refusing to order Mylan to produce requested information about its manufacturing process and the crystal structure of efavirenz in its product

Other industry news of note

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 24 2011

Health Canada has posted information on How to Pay Fees and a Submission Fee Application Form

Minister’s decision to reject NDS at screening stage quashed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 24 2011

In this case, the Hearings Judge dismissed Hospira’s application for judicial review of the Minister of Health’s decision to reject a New Drug Submission (NDS) without prejudice to the ability to refile

Other industry news of note

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 16 2011

Parliament has voted down Bill C-474 - An Act Respecting the Seeds Regulations (analysis of potential harm

Other industry news of note

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 26 2011

The Canadian Chamber of Commerce has recently released a report entitled: Innovation for a Better Tomorrow: Closing Canada's Intellectual Property Gap in the Pharmaceutical Sector

Bayer v. Minister of Health

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 28 2010

The Court of Appeal upheld the decision of the Federal Court, dismissing the application by Bayer for a review of the decision of the Minister of Health refusing to list a patent on the Patent Register in respect of its drug product